» Articles » PMID: 36268261

Long-lasting Dyspnoea in Patients Otherwise Clinically and Radiologically Recovered from COVID Pneumonia: a Probe for Checking Persisting Disorders in Capillary Lung Volume As a Cause

Overview
Specialty Pulmonary Medicine
Date 2022 Oct 21
PMID 36268261
Authors
Affiliations
Soon will be listed here.
Abstract

Background: During SARS-CoV-2 infection, diffuse alveolar damage and pulmonary microvascular abnormalities are critical events that result in gas exchange disorders of varying severity and duration. The only measure of carbon monoxide (CO) diffusing capacity (DL) is unable to distinguish the alveolar from the vascular side of present and residual diffusive abnormalities, and measure of nitric oxide (NO) diffusing capacity (DL) is also recommended. Dyspnoea, despite being understudied, persists in a significant proportion of patients for several weeks after hospital discharge. The goal of this study was to look into the underlying cause of long-term dyspnoea in patients who were "clinically and radiologically recovered" from COVID pneumonia by assessing DL and DL at the same time.

Methods: Patients of both genders, aged ≥18 years, who had a CT scan showing complete resolution of COVID-related parenchymal lesions were recruited consecutively. Spirometrical volumes, blood haemoglobin, SpO, DL, DL and capillary blood volume (Vc) were measured. Data from patients without dyspnoea (group A) and from patients still claiming dyspnoea after 12-16 weeks from their hospital discharge (group B) were statistically compared.

Results: Forty patients were recruited: 19 in group A and 21 in group B. Groups were comparable for their general characteristics and spirometrical volumes, that were in the normal range. Mean values for DL, DL and Vc were significantly and substantially lower than predicted only in patients of group B (p<0.011; p<0.0036; p<0.02; p<0.001, respectively). The DL/ DL ratio was higher in group B (p<0.001) and inversely correlated to Vc values (-0.3636).

Conclusions: The single-breath, simultaneous measurement of DL, DL, and Vc demonstrated that problems with blood gas exchange can persist even after parenchymal lesions have healed completely. Regardless of the normality of spirometric volumes, there was a significant reduction in lung capillary blood volume. In these patients, the cause of long-term dyspnoea may be related to hidden abnormalities in the vascular side of diffusive function. In the near future, novel therapeutic approaches against residual and symptomatic signs of long-COVID are possible.

Citing Articles

Low-Grade Inflammation in Long COVID Syndrome Sustains a Persistent Platelet Activation Associated With Lung Impairment.

Brambilla M, Fumoso F, Conti M, Becchetti A, Bozzi S, Mencarini T JACC Basic Transl Sci. 2025; 10(1):20-39.

PMID: 39958473 PMC: 11830264. DOI: 10.1016/j.jacbts.2024.09.007.


Deciphering Alveolo-Capillary Gas Transfer Disturbances in Patients Recovering from COVID-19 Lung Disease.

Hua-Huy T, Pham-Ngoc H, Aubourg F, Lorut C, Roche N, Dinh-Xuan A J Pers Med. 2024; 14(7).

PMID: 39063992 PMC: 11278216. DOI: 10.3390/jpm14070738.


Post-COVID conditions response: a collaborative approach to -establishing multidisciplinary clinics in Ecuador.

Yepez P, Noboa V, Bolgiano M, Mafla A, Caballero E, Hansoti B Multidiscip Respir Med. 2024; 19.

PMID: 38953789 PMC: 11229825. DOI: 10.5826/mrm.2024.974.


mRNA vaccines protect from the lung microvasculature injury and the capillary blood volume loss occurring in SARS-CoV-2 paucisymptomatic infections.

Dal Negro R, Turco P, Povero M Multidiscip Respir Med. 2024; 19.

PMID: 38833210 PMC: 11186436. DOI: 10.5826/mrm.2024.973.


Gas exchange abnormalities in Long COVID are driven by the alteration of the vascular component.

Imeri G, Conti C, Caroli A, Arrigoni A, Bonaffini P, Sironi S Multidiscip Respir Med. 2024; 19.

PMID: 38577738 PMC: 10968839. DOI: 10.5826/mrm.2024.938.


References
1.
Roughton F, Forster R . Relative importance of diffusion and chemical reaction rates in determining rate of exchange of gases in the human lung, with special reference to true diffusing capacity of pulmonary membrane and volume of blood in the lung capillaries. J Appl Physiol. 1957; 11(2):290-302. DOI: 10.1152/jappl.1957.11.2.290. View

2.
Zavorsky G, Hsia C, Hughes J, D R Borland C, Guenard H, van der Lee I . Standardisation and application of the single-breath determination of nitric oxide uptake in the lung. Eur Respir J. 2017; 49(2). DOI: 10.1183/13993003.00962-2016. View

3.
Zhu N, Zhang D, Wang W, Li X, Yang B, Song J . A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med. 2020; 382(8):727-733. PMC: 7092803. DOI: 10.1056/NEJMoa2001017. View

4.
Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J . Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020; 323(11):1061-1069. PMC: 7042881. DOI: 10.1001/jama.2020.1585. View

5.
Guan W, Ni Z, Hu Y, Liang W, Ou C, He J . Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020; 382(18):1708-1720. PMC: 7092819. DOI: 10.1056/NEJMoa2002032. View